F-star

F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies with the goal of creating a paradigm-shift in cancer therapy F-star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. We are committed to delivering life-changing treatments to those patients with cancer who are not well-served by current therapies through the application of our Modular Antibody Technology™ platform.